Another detected modulator of ECM and better known as protein-related with acute-phase protein, Pentraxin-3, has been implicated in cancer progression, by modulating angiogenesis, metastatic spread, and cancer immune response [62,63]. The gene discussed is PTX3; the disease is cancer.